{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:41:46Z","timestamp":1788572506819,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral research projects merit-based funding in Zhejiang province","award":["ZJ2023021"],"award-info":[{"award-number":["ZJ2023021"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H270002"],"award-info":[{"award-number":["LY22H270002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00182-4","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:39:53Z","timestamp":1746416393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mechanistic insights into synergistic effects using coupled PK-PD modeling"],"prefix":"10.1038","volume":"15","author":[{"given":"Jinzhou","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chumeng","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"182_CR1","doi-asserted-by":"publisher","first-page":"2001571","DOI":"10.1002\/adhm.202001571","volume":"10","author":"F Poustchi","year":"2021","unstructured":"Poustchi, F. et al. Combination therapy of killing diseases by injectable hydrogels: from concept to medical applications. Adv. Healthc. Mater. 10, 2001571. https:\/\/doi.org\/10.1002\/adhm.202001571 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"182_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fphar.2020.00892","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Investigation of invigorating Qi and activating blood circulation prescriptions in treating Qi deficiency and blood stasis syndrome of ischemic stroke patients: study protocol for a randomized controlled trial. Front. Pharmacol. 11, 892. https:\/\/doi.org\/10.3389\/fphar.2020.00892 (2020).","journal-title":"Front. Pharmacol."},{"key":"182_CR3","doi-asserted-by":"publisher","first-page":"722975","DOI":"10.3389\/fphar.2021.722975","volume":"12","author":"J Li","year":"2021","unstructured":"Li, J. et al. Comparison of traditional Chinese medicine in the Long-Term secondary prevention for patients with ischemic stroke: A systematical analysis. Front. Pharmacol. 12, 722975. https:\/\/doi.org\/10.3389\/fphar.2021.722975 (2021).","journal-title":"Front. Pharmacol."},{"key":"182_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3389\/fphar.2020.00946","volume":"11","author":"X Zhai","year":"2020","unstructured":"Zhai, X. et al. Treating different diseases with the same Method-A traditional Chinese medicine concept analyzed for its biological basis. Front. Pharmacol. 11, 946. https:\/\/doi.org\/10.3389\/fphar.2020.00946 (2020).","journal-title":"Front. Pharmacol."},{"key":"182_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.biopha.2017.08.102","volume":"95","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-\u03b2\/Smads and MAPKs signaling activated fibrosis. Biomed. Pharmacother. 95, 461\u2013468. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.102 (2017).","journal-title":"Biomed. Pharmacother"},{"key":"182_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.biopha.2018.05.080","volume":"105","author":"R Ma","year":"2018","unstructured":"Ma, R. et al. Calycosin alleviates cerulein-induced acute pancreatitis by inhibiting the inflammatory response and oxidative stress via the p38 MAPK and NF-\u03baB signal pathways in mice. Biomed. Pharmacother. 105, 599\u2013605. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.080 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"182_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.gene.2018.06.057","volume":"675","author":"L Dong","year":"2018","unstructured":"Dong, L. et al. Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. Gene 675, 94\u2013101. https:\/\/doi.org\/10.1016\/j.gene.2018.06.057 (2018).","journal-title":"Gene"},{"issue":"3","key":"182_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jep.2012.09.056","volume":"144","author":"C Guo","year":"2012","unstructured":"Guo, C. et al. Neuroprotective effect of Calycosin on cerebral ischemia and reperfusion injury in rats. J. Ethnopharmacol. 144 (3), 768\u2013774. https:\/\/doi.org\/10.1016\/j.jep.2012.09.056 (2012).","journal-title":"J. Ethnopharmacol."},{"key":"182_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejphar.2017.11.033","volume":"818","author":"Y Sun","year":"2018","unstructured":"Sun, Y. et al. Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke. Eur. J. Pharmacol. 818, 604\u2013609. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.033 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"182_CR10","doi-asserted-by":"publisher","first-page":"112950","DOI":"10.1016\/j.biopha.2022.112950","volume":"150","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study. Biomed. Pharmacother. 150, 112950. https:\/\/doi.org\/10.1016\/j.biopha.2022.112950 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"182_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.drudis.2009.03.012","volume":"14","author":"XH Ma","year":"2009","unstructured":"Ma, X. H. et al. Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. Drug Discov Today. 14, 579\u2013588. https:\/\/doi.org\/10.1016\/j.drudis.2009.03.012 (2009).","journal-title":"Drug Discov Today"},{"key":"182_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2015.03.035","volume":"168","author":"F Zhao","year":"2015","unstructured":"Zhao, F. et al. A network Pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout. J. Ethnopharmacol. 168, 1\u201316. https:\/\/doi.org\/10.1016\/j.jep.2015.03.035 (2015).","journal-title":"J. Ethnopharmacol."},{"key":"182_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phymed.2018.04.053","volume":"47","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Study on spectrum-effect correlation for screening the effective components in Fangji Huangqi Tang basing on ultra-high performance liquid chromatography-mass spectrometry. Phytomedicine 47, 81\u201392. https:\/\/doi.org\/10.1016\/j.phymed.2018.04.053 (2018).","journal-title":"Phytomedicine"},{"key":"182_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-018-0183-z","volume":"13","author":"R Yan","year":"2018","unstructured":"Yan, R., Yang, Y. & Chen, Y. Pharmacokinetics of Chinese medicines: strategies and perspectives. Chin. Med. 13, 1\u201312. https:\/\/doi.org\/10.1186\/s13020-018-0183-z (2018).","journal-title":"Chin. Med."},{"key":"182_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.11.021","volume":"537","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Uncovering mechanism and efficacy of Salvia Miltiorrhiza-Safflower in cerebral Ischemia-Reperfusion injury. Neuroscience 537, 1\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.11.021 (2024).","journal-title":"Neuroscience"},{"key":"182_CR16","doi-asserted-by":"publisher","first-page":"739864","DOI":"10.3389\/fphar.2021.739864","volume":"12","author":"Y Fangma","year":"2021","unstructured":"Fangma, Y. et al. Hydroxysafflor yellow A and anhydrosafflor yellow B protect against cerebral ischemia\/reperfusion injury by attenuating oxidative stress and apoptosis via the silent information regulator 1 signaling pathway. Front. Pharmacol. 12, 739864. https:\/\/doi.org\/10.3389\/fphar.2021.739864 (2021).","journal-title":"Front. Pharmacol."},{"key":"182_CR17","doi-asserted-by":"publisher","first-page":"154845","DOI":"10.1016\/j.phymed.2023.154845","volume":"115","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Calycosin alleviates cerebral ischemia\/reperfusion injury by repressing autophagy via STAT3\/FOXO3a signaling pathway. Phytomedicine 115, 154845. https:\/\/doi.org\/10.1016\/j.phymed.2023.154845 (2023).","journal-title":"Phytomedicine"},{"key":"182_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0870-1","volume":"14","author":"J Pei","year":"2017","unstructured":"Pei, J. et al. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury. J. Neuroinflammation. 14, 1\u201314. https:\/\/doi.org\/10.1186\/s12974-017-0870-1 (2017).","journal-title":"J. Neuroinflammation"},{"key":"182_CR19","doi-asserted-by":"publisher","first-page":"153532","DOI":"10.1016\/j.phymed.2021.153532","volume":"85","author":"P Huang","year":"2021","unstructured":"Huang, P., Wu, S., Wang, N., Seto, S. & Chang, D. Hydroxysafflor yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore. Phytomedicine 85, 153532. https:\/\/doi.org\/10.1016\/j.phymed.2021.153532 (2021).","journal-title":"Phytomedicine"},{"key":"182_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cpt1979253358","volume":"25","author":"LB Sheiner","year":"1979","unstructured":"Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D. & Ham, J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Ther. 25, 358\u2013371. https:\/\/doi.org\/10.1002\/cpt1979253358 (1979).","journal-title":"Clin. Pharmacol. Ther."},{"key":"182_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.phrs.2018.07.016","volume":"135","author":"P Gelosa","year":"2018","unstructured":"Gelosa, P. et al. Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs). Pharmacol. Res. 135, 60\u201379. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.016 (2018).","journal-title":"Pharmacol. Res."},{"key":"182_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40263-021-00819-8","volume":"35","author":"R Roberti","year":"2021","unstructured":"Roberti, R. et al. Pharmacology of cenobamate: mechanism of action, pharmacokinetics, drug\u2013drug interactions and tolerability. CNS Drugs. 35, 609\u2013618. https:\/\/doi.org\/10.1007\/s40263-021-00819-8 (2021).","journal-title":"CNS Drugs"},{"key":"182_CR23","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1158\/1078-0432.CCR-19-2848","volume":"26","author":"V Pilla Reddy","year":"2020","unstructured":"Pilla Reddy, V. et al. The pharmacokinetic\u2013pharmacodynamic (PKPD) relationships of AZD3229, a novel and selective inhibitor of KIT, in a range of mouse xenograft models of GIST. Clin. Cancer Res. 26, 3751\u20133759. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2848 (2020).","journal-title":"Clin. Cancer Res."},{"key":"182_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/bph.15301","volume":"178","author":"RD Jones","year":"2021","unstructured":"Jones, R. D. et al. A pharmacokinetic\u2013pharmacodynamic model for the MET tyrosine kinase inhibitor, Savolitinib, to explore target Inhibition requirements for anti-tumour activity. Br. J. Pharmacol. 178, 600\u2013613. https:\/\/doi.org\/10.1111\/bph.15301 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"182_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1357-2725(99)00024-2","volume":"32","author":"K Kuida","year":"2000","unstructured":"Kuida, K. Caspase-9. Int. J. Biochem. Cell. Biol. 32, 121\u2013124. https:\/\/doi.org\/10.1016\/S1357-2725(99)00024-2 (2000).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"182_CR26","doi-asserted-by":"publisher","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Interleukins and ischemic stroke. Front. Immunol. 13, 828447. https:\/\/doi.org\/10.3389\/fimmu.2022.828447 (2022).","journal-title":"Front. Immunol."},{"key":"182_CR27","doi-asserted-by":"publisher","first-page":"834114","DOI":"10.3389\/fnagi.2022.834114","volume":"14","author":"MS Zhang","year":"2022","unstructured":"Zhang, M. S. et al. Low serum superoxide dismutase is associated with a high risk of cognitive impairment after mild acute ischemic stroke. Front. Aging Neurosci. 14, 834114. https:\/\/doi.org\/10.3389\/fnagi.2022.834114 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"182_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/antiox11040728","volume":"11","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Hydroxysafflor yellow A blocks HIF-1\u03b1 induction of NOX2 and protects ZO-1 protein in cerebral microvascular endothelium. Antioxidants 11, 728. https:\/\/doi.org\/10.3390\/antiox11040728 (2022).","journal-title":"Antioxidants"},{"key":"182_CR29","doi-asserted-by":"publisher","first-page":"106316","DOI":"10.1016\/j.intimp.2020.106316","volume":"82","author":"J Ye","year":"2020","unstructured":"Ye, J. et al. Hydroxysafflor yellow A inhibits hypoxia\/reoxygenation-induced cardiomyocyte injury via regulating the AMPK\/NLRP3 inflammasome pathway. Int. Immunopharmacol. 82, 106316. https:\/\/doi.org\/10.1016\/j.intimp.2020.106316 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"182_CR30","doi-asserted-by":"publisher","first-page":"35319","DOI":"10.1038\/srep35319","volume":"6","author":"D Han","year":"2016","unstructured":"Han, D. et al. Hydroxysafflor yellow A alleviates myocardial ischemia\/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling. Sci. Rep. 6, 35319. https:\/\/doi.org\/10.1038\/srep35319 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00182-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:39:53Z","timestamp":1746416393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00182-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00182-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15631"}}